Adapalene by Actavis Pharma, Inc. ADAPALENE GEL, 0.1%

Adapalene by

Drug Labeling and Warnings

Adapalene by is a Otc medication manufactured, distributed, or labeled by Actavis Pharma, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ADAPALENE- adapalene gel 
Actavis Pharma, Inc.

----------

ADAPALENE GEL, 0.1%

Drug Facts

Active ingredient
Adapalene, USP 0.1%
 (retinoid)*
*read consumer information leaflet

Purpose

Acne Treatment

Use

  • For the treatment of acne

Warnings

For external use only

Do not use

  • on damaged skin (cuts, abrasions, eczema, sunburn)
  • if you are allergic to adapalene or any of the ingredients in this product.

If pregnant or breast-feeding, ask a doctor before use.

When using this product

  • limit sun exposure, including light from tanning beds, and use sunscreen when going outdoors
  • do not wax to remove hair in areas where the product has been applied
  • during the early weeks of use, your acne may appear to worsen before it improves (this is normal); continue using as directed, unless you get irritation that becomes severe
  • irritation (redness, itching, dryness, burning) is more likely to occur:
  • in the first few weeks of use
  • if using more than one topical acne medication at a time
  • but irritation usually lessens with continued use of this product
  • it may take up to 3 months of once daily use to see results
  • avoid product contact with eyes, lips, and mouth. If contact occurs, immediately flush the area with water.
  • wash hands after use

Stop use and a ask doctor if

  • you become pregnant, or are planning to become pregnant, while using the product
  • you have symptoms of an allergic reaction (such as itching, rash, hives, swelling of the lips, eyelids, and shortness of breath)
  • irritation becomes severe
  • you see no improvement after 3 months of once daily use

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions
Adults and children 12 years of age and older:

  • use once daily
  • clean the skin gently and pat dry before applying the product
  • cover the entire affected area with a thin layer. For example, if your acne is on the face, apply the product to the entire face.
  • do not use more than one time a day. Applying more than directed will not provide faster or better results, but may worsen skin irritation.

Children under 12 years of age: ask a doctor

Other information

  • store at room temperature 68°-77°F
  • protect from freezing

Inactive ingredients

carbomer homopolymer type C, edetate disodium, methylparaben, poloxamer 182, propylene glycol, purified water
May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

Questions?

1-888-838-2872 between 9 am and 5 pm ET, Monday – Friday.

PRINCIPAL DISPLAY PANEL

NDC 0591-0375-86

Adapalene
Gel USP 
0.1%
Acne Treatment

Compare to the active ingredient in Differin® Gel †

  • Previously available only by prescription
  • Once Daily Topical Retinoid*
  • Oil Free
  • Fragrance Free

*Read consumer information leaflet before use

NET WT 0.5 OZ (15g)

image
ADAPALENE 
adapalene gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 0591-0375
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ADAPALENE (UNII: 1L4806J2QF) (ADAPALENE - UNII:1L4806J2QF) ADAPALENE1 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POLOXAMER 182 (UNII: JX0HIX6OAG)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 0591-0375-891 in 1 CARTON11/30/202311/30/2023
145 g in 1 TUBE; Type 0: Not a Combination Product
2NDC: 0591-0375-861 in 1 CARTON11/30/202311/30/2023
215 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09096211/30/202311/30/2023
Labeler - Actavis Pharma, Inc. (119723554)

Revised: 1/2024
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.